Gemigliptin Market Share: Global Key Findings, Industry Demand, Regional Analysis, Key Players Profiles, Future Prospects and Growth Forecast 2024- 2033
Gemigliptin is a new drug developed by Daiichi Sankyo, Inc. It is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor, used to treat type 2 diabetes mellitus. …
